133 related articles for article (PubMed ID: 22410782)
41. Metastasis in an orthotopic murine model of melanoma is independent of RAS/RAF mutation.
Rozenberg GI; Monahan KB; Torrice C; Bear JE; Sharpless NE
Melanoma Res; 2010 Oct; 20(5):361-71. PubMed ID: 20679910
[TBL] [Abstract][Full Text] [Related]
42. Promotion of invasion by mutant RAS is dependent on activation of the WASF3 metastasis promoter gene.
Teng Y; Ngoka L; Cowell JK
Genes Chromosomes Cancer; 2017 Jun; 56(6):493-500. PubMed ID: 28233357
[TBL] [Abstract][Full Text] [Related]
43. Significance of prohibitin domain family in tumorigenesis and its implication in cancer diagnosis and treatment.
Yang J; Li B; He QY
Cell Death Dis; 2018 May; 9(6):580. PubMed ID: 29784973
[TBL] [Abstract][Full Text] [Related]
44. Prohibitin plays a role in the functional plasticity of macrophages.
Xu YXZ; Ande SR; Ikeogu NM; Zhou K; Uzonna JE; Mishra S
Mol Immunol; 2022 Apr; 144():152-165. PubMed ID: 35219912
[TBL] [Abstract][Full Text] [Related]
45. Signaling pathways of prohibitin and its role in diseases.
Zhou TB; Qin YH
J Recept Signal Transduct Res; 2013; 33(1):28-36. PubMed ID: 23327602
[TBL] [Abstract][Full Text] [Related]
46. Prohibitin, relocated to the front ends, can control the migration directionality of colorectal cancer cells.
Ma LL; Shen L; Tong GH; Tang N; Luo Y; Guo LL; Hu CT; Huang YX; Huang G; Jing FY; Liu C; Li ZY; Zhou N; Yan QW; Lei Y; Zhu SJ; Cheng ZQ; Cao GW; Deng YJ; Ding YQ
Oncotarget; 2017 Sep; 8(44):76340-76356. PubMed ID: 29100316
[TBL] [Abstract][Full Text] [Related]
47. The Mitochondrial Prohibitin (PHB) Complex in
Lourenço AB; Artal-Sanz M
Metabolites; 2021 Sep; 11(9):. PubMed ID: 34564452
[TBL] [Abstract][Full Text] [Related]
48. "Prohibitin"g CRAF/MAPK activation with rocaglamides.
Rajalingam K; Rudel T
Chem Biol; 2012 Sep; 19(9):1077-8. PubMed ID: 22999872
[TBL] [Abstract][Full Text] [Related]
49. MIG-7 and phosphorylated prohibitin coordinately regulate lung cancer invasion/metastasis.
Ho MY; Liang CM; Liang SM
Oncotarget; 2015 Jan; 6(1):381-93. PubMed ID: 25575814
[TBL] [Abstract][Full Text] [Related]
50. Akt phosphorylates Prohibitin 1 to mediate its mitochondrial localization and promote proliferation of bladder cancer cells.
Jiang L; Dong P; Zhang Z; Li C; Li Y; Liao Y; Li X; Wu Z; Guo S; Mai S; Xie D; Liu Z; Zhou F
Cell Death Dis; 2015 Feb; 6(2):e1660. PubMed ID: 25719244
[TBL] [Abstract][Full Text] [Related]
51. Recombinant protein rVP1 upregulates BECN1-independent autophagy, MAPK1/3 phosphorylation and MMP9 activity via WIPI1/WIPI2 to promote macrophage migration.
Liao CC; Ho MY; Liang SM; Liang CM
Autophagy; 2013 Jan; 9(1):5-19. PubMed ID: 23051912
[TBL] [Abstract][Full Text] [Related]
52. Prohibitin 2 represents a novel nuclear AKT substrate during all-trans retinoic acid-induced differentiation of acute promyelocytic leukemia cells.
Bavelloni A; Piazzi M; Faenza I; Raffini M; D'Angelo A; Cattini L; Cocco L; Blalock WL
FASEB J; 2014 May; 28(5):2009-19. PubMed ID: 24522204
[TBL] [Abstract][Full Text] [Related]
53. Prohibitins role in cellular survival through Ras-Raf-MEK-ERK pathway.
Chowdhury I; Thompson WE; Thomas K
J Cell Physiol; 2014 Aug; 229(8):998-1004. PubMed ID: 24347342
[TBL] [Abstract][Full Text] [Related]
54. A role for prohibitin in mast cell activation: location matters.
Yurugi H; Rajalingam K
Sci Signal; 2013 Sep; 6(292):pe29. PubMed ID: 24023253
[TBL] [Abstract][Full Text] [Related]
55. Prohibitin ligands in cell death and survival: mode of action and therapeutic potential.
Thuaud F; Ribeiro N; Nebigil CG; Désaubry L
Chem Biol; 2013 Mar; 20(3):316-31. PubMed ID: 23521790
[TBL] [Abstract][Full Text] [Related]
56. The natural anticancer compounds rocaglamides inhibit the Raf-MEK-ERK pathway by targeting prohibitin 1 and 2.
Polier G; Neumann J; Thuaud F; Ribeiro N; Gelhaus C; Schmidt H; Giaisi M; Köhler R; Müller WW; Proksch P; Leippe M; Janssen O; Désaubry L; Krammer PH; Li-Weber M
Chem Biol; 2012 Sep; 19(9):1093-104. PubMed ID: 22999878
[TBL] [Abstract][Full Text] [Related]
57. Targeting prohibitins with chemical ligands inhibits KRAS-mediated lung tumours.
Yurugi H; Marini F; Weber C; David K; Zhao Q; Binder H; Désaubry L; Rajalingam K
Oncogene; 2017 Aug; 36(33):4778-4789. PubMed ID: 28414306
[TBL] [Abstract][Full Text] [Related]
58. PHB2 (prohibitin 2) promotes PINK1-PRKN/Parkin-dependent mitophagy by the PARL-PGAM5-PINK1 axis.
Yan C; Gong L; Chen L; Xu M; Abou-Hamdan H; Tang M; Désaubry L; Song Z
Autophagy; 2020 Mar; 16(3):419-434. PubMed ID: 31177901
[TBL] [Abstract][Full Text] [Related]
59. UBXN1 promotes liver tumorigenesis by regulating mitochondrial homeostasis.
Jiao K; Xu G; Liu Y; Yang Z; Xiang L; Chen Z; Xu C; Zuo Y; Wu Z; Zheng N; Xu W; Zhang L; Liu Y
J Transl Med; 2024 May; 22(1):485. PubMed ID: 38773518
[TBL] [Abstract][Full Text] [Related]
60. PTPLAD1 Regulates PHB-Raf Interaction to Orchestrate Epithelial-Mesenchymal and Mitofusion-Fission Transitions in Colorectal Cancer.
Huang ZJ; Li YJ; Yang J; Huang L; Zhao Q; Lu YF; Hu Y; Zhang WX; Liang JZ; Pan J; Pan YL; He QY; Wang Y
Int J Biol Sci; 2024; 20(6):2202-2218. PubMed ID: 38617530
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
